Intrexon Corporation

NASDAQ: XON
$3.29
-$0.67 (-16.9%)
Closing price June 3, 2020
Weight Watchers, Intrexox, American Midstream Partners, and Dean Foods all posted new 52-week lows Monday.
Paul Ausick
Ziopharm Oncology saw its shares slide early on Friday after the company announced the pricing of its secondary offering.
Chris Lange
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Lee Jackson
With earnings season starting to wind down, investors will have to look hard for reasons to keep the tired bull market rolling.
Lee Jackson
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable companies targeting...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include CenturyLink, International Paper, Kroger, On Deck Capital, Phillips 66 and United Technologies.
Jon C. Ogg
One interesting tidbit to this week's insider trading was all the energy stocks that are showing up. It is clear many insiders feel the bottom is close and now is the time to buy shares.
Lee Jackson
When two stocks run up over 50% and 30% on the same news, investors have to wonder if the move in the stock was justified or if the news-pop was due to trading factors and sentiment.
Chris Lange
Source: ThinkstockOn Thursday, Twitter finally revealed key information about itself and its initial public offering (IPO). While investors no doubt are excited about the company’s compelling...
Jon C. Ogg
You know it is a good bull market when you have many initial public offerings (IPOs) trading up more than 50% from their debut in just a few short weeks or months. 24/7 Wall St. tracks IPOs from time...
Jon C. Ogg
Source: Jon OggLabor Day is behind us and attendance should be starting back with interest in the markets again. Each morning 24/7 Wall St. reviews literally dozens and dozens of Wall Street analyst...
Jon C. Ogg